Updates are available Correction dated 2025-06-11
Click to view Correction: https://doi.org/10.1038/s41541-025-01175-0
-
Authors
Wojcechowskyj, Jason A.
Jong, Robyn M.
Mäger, Imre
Flach, Britta
Munson, Paul V.
Mukherjee, Progya P.
Mertins, Barbara
Barcay, Katherine R.
Folliard, Thomas
- License Information
-
More Information
Article History
Received: 12 January 2025
Accepted: 14 April 2025
First Online: 29 April 2025
Change Date: 11 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41541-025-01175-0
Competing interests
: The authors declare the following competing interests: All authors currently hold equity in and were employed by ExcepGen Inc. at the time of this study. ExcepGen Inc is an applicant for the following patents, pending in the US and other countries, based on this work. B.M. and T.F. are inventors of WO 2021/055369 for compositions and methods for enhancing protein expression using an NCT inhibitor protein. B.M., T.F., and I.M. are inventors of WO 2022/192694 for compositions and methods for enhancing protein expression using an NCT inhibitor protein. B.M., T.F., and I.M. are inventors of WO 2022/197940 for compositions and methods for vaccines using an NCT inhibitor protein. B.M., T.F., I.M., and J.A.W. are inventors of WO 2023/183889 for compositions and methods for protein expression using RNA encoding an NCT inhibitor protein.
